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Abstract
Background Several studies have suggested no difference
in the liver function of early gastric cancer (EGC) patients
with liver cirrhosis (LC) between laparoscopic and open
distal gastrectomy. However, the number of patients and
comparison of long-term survival rates between the two
groups are limited. The purpose of this study was to
compare the long-term survival and immediate postopera-
tive liver function of EGC patients with LC after laparo-
scopic and open distal gastrectomy.
Materials and methods The clinical data of EGC patients
with LC who had no other malignancy and underwent
distal gastrectomy at Asan Medical Center between Jan-
uary 2005 and April 2013 were investigated retrospec-
tively. All patients were divided into two groups: the open
group (OG) and laparoscopic group (LG). The clinico-
pathologic data of the two groups were compared.
Results The number of patients in each group was 48 and
27 in the OG and LG, respectively. There were no signif-
icant differences in the age, sex ratio, ASA score, cause of
liver cirrhosis, preoperative Child-Pugh classification,
tumor location, TNM stage, total postoperative drain
amount, albumin, total bilirubin, alkaline phosphatase,
alanine aminotransferase, prothrombin time, morbidity and
recurrence rate. Shorter hospital stay, longer operative time
and more retrieved lymph nodes were observed in LG. The
long-term overall survival rate was not different between
the two groups (P = 0.356).
Conclusions ForEGCpatientswith liver cirrhosis, especially
Child A cirrhosis, laparoscopic or laparoscopy-assisted distal
gastrectomy can be a safe surgical procedure in comparison to
open distal gastrectomy in terms of the long-term survival rate
and immediate postoperative liver function.
Keywords Gastric cancer  Laparoscopic gastrectomy 
Liver cirrhosis  Survival
Introduction
Gastric cancer and liver cirrhosis are major public health
concerns in Korea. Gastric cancer is the one of the most
common cancers in Korea. The age-standardized incidence
rate of gastric cancer is 59.3 and 23.5 per 100,000 people in
males and females, respectively [1]. Chronic liver disease,
including liver cirrhosis, is also very common in Korea,
ranking as the eighth leading cause of death in South Korea
in 2013. The mortality rate due to chronic liver disease in
Korea was reported as 13.2 per 100,000 people with the
peak mortality in middle-aged males, suggesting a heavy
disease burden on families and society [2].
A study from Korea showed 2.0% of cirrhotic patients
had gastric cancer. The study presented radical open gas-
trectomy with extended lymph node dissection as feasible
in patients with compensated liver cirrhosis [3]. For
patients with moderate to severe hepatic dysfunction,
however, D1 or less extensive lymph node dissection with
meticulous hemostasis may be the more reasonable surgi-
cal procedure, and radical gastrectomy is very dangerous,
even fatal, for Child C patients [4, 5].
Although laparoscopic gastrectomy as the standard pro-
cedure for early gastric cancer is still a commentary on
investigational treatment [6], the number of laparoscopic
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gastrectomies is increasing with comparable results to open
gastrectomy [7], and laparoscopic gastrectomy can be con-
sidered an option in general clinical practice to treat cStage I
cancer [8]. Although technically challenging because of
portal hypertension, varices and thrombocytopenia, basic
and advanced laparoscopic procedures may be safe for
patients with Child A and B liver cirrhosis [9]. There are a
few studies on laparoscopic gastrectomy for early gastric
cancer in liver cirrhotic patients that have demonstrated that
laparoscopic gastrectomy is a feasible surgical procedure in
terms of postoperative liver function and complications
[10, 11]. However, studies directed at the comparison of the
long-term survival rate between open distal gastrectomy and
laparoscopic distal gastrectomy are limited. In this study, we
compared open distal gastrectomy and laparoscopic or
laparoscopy-assisted distal gastrectomy for early gastric
cancer in terms of immediate postoperative liver function
and long-term survival in relation to oncology safety with
more patients than previous studies.
Methods
Patients
Preoperative early gastric cancer (EGC) patients with liver
cirrhosis who had no other malignant diseases, including
hepatocellular carcinoma, and had undergone distal gas-
trectomy at Asan Medical Center between January 2005
and April 2013 were enrolled after institutional review
board approval (#2015–1274).
Preoperative evaluation
The patients were divided into two groups: open gastrectomy
(OG) vs. laparoscopic or laparoscopy-assisted gastrectomy
(LG). Liver cirrhosis (LC)was diagnosed based on the history
of liver disease or a preoperative imaging study such as CT or
USG.Age, sex,AmericanSociety ofAnesthesiologists (ASA)
score, the cause of liver cirrhosis, preoperative Child-Pugh
classification, CEA/CA19-9/AFP, location of the tumor,
TNM stage, daily and total postoperative surgical drain
amount, pre- and postoperative albumin, total bilirubin,
alkaline phosphatase, alanine aminotransferase and pro-
thrombin time, postoperative morbidity, hospital stay after
operation, the operative time, extent of lymphnodedissection,
count of retrieved lymph nodes, recurrence rate, recurrence-
free survival and overall survival rates were analyzed.
Surgical indications
Open or laparoscopic gastrectomy was chosen according to
the preference and experience of the surgeons. In addition,
the patients’ requests were considered in the choice of
surgical procedure in the early period of this study because
national medical insurance in Korea did not cover laparo-
scopic surgery and the costs of laparoscopic surgery were
higher than those of open surgery.
Surgical procedure
Laparoscopic gastrectomy was done with five ports and a
3-cm infraumbilical incision for telescope and specimen
retrieval. The anastomosis was done intracorporeally with
the Billroth type I, Billroth type II, Roux-en-Y gastroje-
junostomy or uncut Roux-en-Y gastrojejunostomy recon-
struction methods. Laparoscopy-assisted distal gastrectomy
was done with five ports with a 4–5-cm upper midline
incision for specimen retrieval and extracorporeal anasto-
mosis. The pneumoperitoneum was maintained at
12 mmHg. LN dissection was scored according to the
Japanese gastric cancer treatment guidelines [6]. To retract
the liver, the attachment site of the lesser omentum to the
right diaphragmatic crus was sutured intracorporeally, and
then a thread (2/0 prolene straight; Covidien, Mansfield,
MA) was pulled by a suture passer was tied over the skin in
the xiphoid process area [12].
Data collection and statistical analysis
Electronic medical records, operative notes and patholog-
ical reports were retrospectively reviewed, and data were
collected. SPSS version 20 software was used for statistical
analysis. Chi-square test, Fischer’s exact test, Student’s
t test and Kaplan-Meyer survival analysis with the log-rank
(Mantel-Cox) test were used for comparison. P\0.05 was
considered significant.
Results
A total of 75 patients were enrolled in this study. The
number of patients was 48 in the OG and and 27 in the LG.
Patient demographics are summarized in Table 1. There
were no significant differences in the age, sex ratio,
underlying disease and preoperative Child-Pugh classifi-
cation between the two groups. There were no Child C
patients. The ASA score, cause of liver cirrhosis, location
of the tumor, TNM stage, preoperative CEA/CA19-9/AFP,
albumin, total bilirubin, alkaline phosphatase, alanine
aminotransferase and prothrombin time all were not sig-
nificant (Tables 2, 3). The operative time was longer and
the numbers of retrieved lymph nodes were more in the LG
than OG. The extent of LN dissection was significant. D0
occurred more in the OG and D2 more in the LG. Hospital
stay was longer in the OG than LG (Table 3). During the
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first 6 days, postoperative liver function tests were not
different, except for AST on the 3rd and 6th day after
surgery, which was higher in the OG (Table 2).
Morbidity and mortality
There was no significant difference in either the daily or
total postoperative surgical drain amount, although the
amount was less in the LG (1127 ± 1876 vs.
2037 ± 1763 ml in OG P value = 0.053). Nine patients
(18.78%) had immediate postoperative complications in
the OG; seven of them had grade 2 severity based on the
Clavien-Dindo Classification, one patient had grade 1 and
one patient had grade 5, who died from postoperative
bleeding and liver failure in the OG. Four patients (14.8%)
in the LG had immediate postoperative complications; two
of them had grade 1 and two had grade 2, which were not
statistically significant between the OG and LG
(P = 0.654). Details of complications are listed in
Table 4.
Recurrence and long-term survival
Recurrences of gastric cancer were detected in three cases.
First, a 62-year-old male with Child-Pugh A liver cirrhosis
underwent open distal gastrectomy, gastrojejunostomy
with Braun jejunojejunostomy and D0 lymph node dis-
section for EGC in the lesser curvature of the antrum. The
pathologic stage was T1bN0M0. He was discharged on the
12th postoperative day without complications. Lymph
node recurrence was detected in the lesser curvature side of
the remnant stomach and supraceliac area 10.7 months
after surgery. He died from gastric cancer progression
21.2 months after surgery. Second, a 48-year-old male with
Child-Pugh A liver cirrhosis underwent open distal gas-
trectomy, gastroduodenostomy and D0 lymph node dis-
section for EGC in the lesser curvature of the antrum. The
pathologic stage was T1bN0M0. He was discharged on
postoperative day 14 after ascites and pleural effusion
management. The hepatic recurrence was detected
24.4 months after surgery. He died from liver failure
34.6 months after surgery. Third, a 71-year-old male with
Child-Pugh A liver cirrhosis underwent laparoscopy-as-
sisted distal gastrectomy, gastroduodenostomy and D2
lymph node dissection for EGC in the greater curvature of
the body. The pathologic stage was T1bN1M0. He was
discharged on postoperative day 7 without complications.
The hepatic recurrence was detected 3.8 months after
surgery. He had been followed up for 17.2 months post-
operatively but was then lost to follow up.
Regarding the operative procedure, the recurrence-free
survival rate was also not different between the two groups
(OG, 94.9%; LG, 96.2%; P = 0.893) (Fig. 1a). The overall
survival rate was not different between the two groups
(OG, 74.8%, LG, 91.8%; P = 0.356) (Fig. 1b). There was
no significant difference in recurrence rate between the two
groups (Table 5). In the long-term follow-up, eight patients
died in the OG: two patients from gastric cancer, four
patients from liver disease and two patients from other
reasons, while two patients in the LG died from causes
unrelated to gastric cancer (Table 5).
The overall survival rate according to the extent of
lymph node dissection was compared, and no difference
was observed (P = 0.394).
Discussion
In a place with high incidence of gastric cancer and liver
cirrhosis, surgeons often operate on gastric cancer patients
with liver cirrhosis. Because of screening programs, early
diagnosis, advanced surgical techniques and improving
postoperative management, the mortality and morbidity
associated with gastric cancer surgery have decreased at
present.
Laparoscopic gastrectomy has become a common pro-
cedure for EGC in countries with a high incidence of early
gastric cancer. Pneumoperitoneum and lymph node dis-
section were a concern for mortality and morbidity in
Table 1 Patient demographics
Total no. = 75 OG (48) LG (27) P value
Age (years, mean ± SD) 58.4 ± 9.6 59.6 ± 9.7 0.607
Sex (male/female) 43/5 23/4 0.714
Underlying disease
DM 14 3 0.090
HTN 13 11 0.303
Arrhythmia 1 0 1.00
Pulmonary TB 2 2 0.616
Previous abdominal surgery 0 1 0.360
ASA score









A 43 24 1.00
B 5 3
OG open gastrectomy group, LG laparoscopic or laparoscopic-as-
sisted gastrectomy group, ASA American Society of Anesthesiologists
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laparoscopic gastrectomy for gastric cancer patients with
liver cirrhosis because decreased portal venous return may
lead to liver ischemia and increase ascites, and dissected
lymphatic channels may increase portal pressure in case of
cirrhosis [13].
In our study, during the first 6 days, postoperative liver
function tests were not different, except for the AST on the
3rd and 6th day and ALT on the 6th day after surgery,
which was higher in the OG than LG. Because AST and
ALT were normalized from the 6th day after surgery in
both groups, clinical impact was thought to be minimal. Its
result was similar to that of other studies [11].
The total drain amount until the 6th postoperative day
was not statistically different between two groups
although the extent of lymph node dissection was less in
the OG. This result did not support the concern of
increasing ascites with more LN dissection. We think
this is due to less visceral exposure and bowel manip-
ulation in the LG in which more lymph node dissections
were performed.
In terms of liver function and ascites, the morbidity in
the LG was comparable to that in the OG. This showed the
safety and benefit of the laparoscopic approach in liver
cirrhosis patients.
Table 2 Pre- and postoperative
day 1, 3 and 6 laboratory tests
Preop laboratory test OG (48) LG (27) P value
Albumin (g/dl) 3.8 ± 0.6 3.7 ± 0.5 0.571
AST (IU/l) 45.5 ± 52.7 32.1 ± 13.8 0.100
ALT (IU/l) 34.7 ± 31.1 29.3 ± 18.4 0.408
Alkaline phosphatase (IU/l) 75.3 ± 23.9 90.7 ± 45.3 0.060
Total bilirubin (mg/dl) 0.9 ± 0.3 0.9 ± 0.3 0.852
Prothrombin time (INR) 1.1 ± 0.2 1.1 ± 0.1 0.603
Prothrombin time (%) 88.6 ± 17.6 89.1 ± 15.5 0.912
AFP (ng/ml) 21.9 ± 53.3 6.8 ± 9.0 0.437
CEA (ng/ml) 1.7 ± 1.2 2.2 ± 1.4 0.166
CA19-9 (U/ml) 17.9 ± 28.4 10.3 ± 9.3 0.260
POD#1 laboratory tests
Albumin (g/dl) 3.0 ± 0.4 3.0 ± 0.3 0.821
AST (IU/l) 62.9 ± 77.0 61.0 ± 46.1 0.907
ALT (IU/l) 47.9 ± 61.4 54.9 ± 44.8 0.610
Alkaline phosphatase (IU/l) 59.0 ± 19.2 89.8 ± 117.6 0.189
Total bilirubin (mg/dl) 1.3 ± 0.5 1.3 ± 0.6 0.595
Prothrombin time (INR) 1.24 ± 0.3 1.26 ± 0.04 0.796
Drain amount (ml) 240 ± 305 220 ± 374 0.827
POD#3 laboratory tests
Albumin (g/dl) 3.0 ± 0.4 2.9 ± 0.4 0.811
AST (IU/l) 39.3 ± 28.9 28.1 ± 10.5 0.024
ALT (IU/l) 38.4 ± 39.7 31.4 ± 21.6 0.407
Alkaline phosphatase (IU/l) 54.8 ± 14.4 58.1 ± 20.8 0.432
Total bilirubin (mg/dl) 1.3 ± 0.8 1.3 ± 0.7 0.726
Prothrombin time (INR) 1.25 ± 0.24 1.29 ± 0.03 0.613
Drain amount (ml) 341 ± 369 220 ± 338 0.200
POD#6 laboratory tests
Albumin (g/dl) 3.1 ± 0.4 3.0 ± 0.3 0.641
AST (IU/l) 33.7 ± 12.6 28.5 ± 6.3 0.033
ALT (IU/l) 38.5 ± 34.5 22.6 ± 13.9 0.040
Alkaline phosphatase (IU/l) 65.4 ± 19.8 68.8 ± 29.8 0.606
Total bilirubin (mg/dl) 1.4 ± 1.5 1.2 ± 0.5 0.471
Prothrombin time (INR) 1.27 ± 0.28 1.23 ± 0.18 0.762
Drain amount (ml) 310 ± 352 173 ± 254 0.182
OG open gastrectomy group, LG laparoscopic or laparoscopic-assisted gastrectomy group, POD# post-
operative day number
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The main disadvantage of LG is the longer operative
time. There were no bleeding complications in the LG,
which could be because of the better magnified visualiza-
tion, use of ultrasonic shears for better hemostasis and the
easy accessibility of the deep operative field. Cheng et al.
reported a meta-analysis on the advantage of using ultra-
sonic shears compared conventional techniques: shorter
operating time, reduced intraoperative blood loss and
decreased drainage amount [14].
There is no guideline for lymph node dissection for
gastric cancer patients with liver cirrhosis. The most
common postoperative complication of these patients is
massive ascites related to lymph node dissection [3, 15]. In
this study, D2 lymph node dissection was more commonly
performed in the LG although D2 lymph node dissection
was not thought to be advisable for EGC patients even with
liver cirrhosis. However, according to the Japanese
guideline for cT1 N? patients, standard gastrectomy with
D2 lymph node dissection is recommended. Under
laparoscopic view, the size of the lymph nodes might be
exaggerated compared to the real ones, and operators might
regard these lymph nodes as metastatic ones and perform
D2 lymph node dissection during laparoscopic surgery.
Similar results could also be found in other Korean studies
in which D2 lymph node dissection for gastric cancer
patients with liver cirrhosis was performed in 9 out of 18
(50%) during laparoscopy-assisted distal gastrectomy [11].
According to liver function, the cause of death can differ.
The causes of death for gastric cancer patients with Child A
cirrhosis and Child B or C were usually related to gastric
cancer recurrence and liver failure/hepatocellular carcinoma,
respectively [4, 16]. Therefore, D2 lymph node dissection
can be recommended for gastric cancer patients with Child
A cirrhosis while less than D2 lymph node dissection can be
considered for gastric cancer patients with Child B or C.
Furthermore, hepatocellular carcinoma can develop in early
gastric cancer patients with liver cirrhosis after gastric
cancer surgery. Ikeda et al. reported the most common cause
of death in EGC was hepatocellular carcinoma (4 of 9
deaths) [17]. Therefore, during the postoperative follow-up
period, early diagnosis of hepatocellular carcinoma is
important for EGC patients with liver cirrhosis.
Table 3 Operative details
OG (48) LG (27) P value
Extent of LN dissectiona













Op time (min) 134.4 ± 41.0 153.4 ± 47.9 0.076
No. of retrieved LNs 20.3 ± 9.7 30.6 ± 15.3 0.003
Hospital stay (days) 14.5 ± 6.2 11.2 ± 3.7 0.005
Drain amount until POD#6 1851 ± 1772 1177 ± 1866 0.157
a According to the 2010 Japanese gastric cancer treatment guidelines
(ver. 3) [6]
OG open gastrectomy group, LG laparoscopic or laparoscopic-as-
sisted gastrectomy group, LN lymph node, GD gastrodeudenal anas-
tomosis, GJ gastrojejunal anastomosis, GJJJ gastrojejunal with
jejunojejunal anastomosis, RYGJ Roux-en-Y gastrojejunal anasto-
mosis, POD# postoperative day number
Table 4 Morbidity and mortality
OG (48) LG (27) P value
Complications severitya
None 39 (81.3%) 23 (85.2%) 0.464
Grade I 1 (2.1%) 2 (7.4%)
Grade II 7 (14.6%) 2 (7.4%)
Grade V 1 (2.1%) 0 (0.0%)
Morbidity







RBC 3 0 0.549
FFP 1 0 1.000
In-hospital mortality 1 0 1.000
OG open gastrectomy group, LG laparoscopic or laparoscopic-as-
sisted gastrectomy group
a The Clavien-Dindo classification of surgical complications. Grade
I: any deviation from the normal postoperative course without the
need for pharmacological treatment or surgical, endoscopic or radi-
ological interventions. Allowed therapeutic regimens are: drugs as
antiemetics, antipyretics, analgesics, diuretics and electrolytes and
physiotherapy, including wound infections opened at the bedside.
Grade II: requiring pharmacological treatment with drugs other than
those allowed for grade I complications. Blood transfusions and total
parenteral nutrition are also included. Grade IIIa: requiring surgical,
endoscopic or radiological intervention not under general anesthesia;
grade IIIb: an intervention under general anesthesia. Grade IVa: a
life-threatening complication (including CNS complications) ? re-
quiring IC/ICU management with single-organ dysfunction (including
dialysis); grade IVb: multiorgan failure. Grade V: death of the patient
Comparison of long-term survival and immediate postoperative liver function after…
123
The decision concerning the treatment strategy is more
complicated in case of gastric cancer patients with Child B
rather than Child A cirrhosis. Both the life expectancy of
patients with liver cirrhosis and the chance of gastric
cancer progression should be considered in the treatment
strategy. However, there have been few studies about the
indications for gastrectomy for gastric cancer patients with
Child B cirrhosis. Lee et al. just showed the overall 5-year
survival rate of gastric cancer patients (51 stage I patients
out of a total 94 patients) with Child A and B and C
Fig. 1 Long-term survival.
a Recurrence-free survival;
b overall survival
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cirrhosis was 69.1 and 44.4%, respectively [3]. Considering
this result, gastrectomy can be recommended even for
patients with Child B cirrhosis, with the overall 5-year
survival rate being over 40% in Child B and C if gastric
cancer was detected at an early stage. Before surgery,
downstaging of Child B to Child A cirrhosis is required if
possible.
Our study has certain limitations. First, this study was
retrospective and just carried out at a single center.
Therefore, it had the limitation of generalization. Fur-
thermore, the allocation of the operative approach to
either LG or OG included a selection bias. The OG
group might have included more patients with poor
physical condition than the LDG group, although the
ASA score and Child-Pugh classification showed no
significant difference between the two groups. Second,
an important factor during surgery is the amount of
intraoperative blood loss, especially in liver cirrhosis
patients. In this study, however, the data were not
available for all the patients and could not be collected
precisely. Therefore, the transfusion amount could be
compared between the two groups indirectly, and no
difference was observed. Third, there was no information
about ligation of the hepatic branch from the left gastric
artery in each group. These could be really important
data on the immediate liver function and long-term
outcomes of liver cirrhosis patients. However, data about
aberrant hepatic branch ligation could not be used in this
retrospective study. Similarly, portal hypertension also
can affect postoperative outcomes. However, accurate
data about portal hypertension could not be collected
because of the limitations of retrospective data.
Conclusion
For EGC patients with liver cirrhosis, especially Child A
cirrhosis, laparoscopic or laparoscopy-assisted distal gas-
trectomy can be a safe surgical procedure for comparison
of open distal gastrectomy in terms of the long-term sur-
vival rate and immediate postoperative liver function.
Compliance with ethical standards
Conflict of interest The authors disclose no potential conflicts of
interest.
Human rights statement and informed consent All procedures
followed were in accordance with the ethical standards of the
responsible committee on human experimentation (institutional and
national) and with the Helsinki Declaration of 1964 and later versions.
Informed consent or substitute for it was obtained from all patients for
being included in the study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al.
Cancer statistics in Korea: incidence, mortality, survival, and
prevalence in 2012. Cancer Res Treat. 2015;47(2):127–41.
2. Statistics Korea: Annual report on the cause of death statistics.
Korean Statistical Information Service. http://kostat.go.kr.
(2013). Accessed 2015.
3. Lee JH, Kim J, Cheong JH, Hyung WJ, Choi SH, Noh SH.
Gastric cancer surgery in cirrhotic patients: result of gastrectomy
with D2 lymph node dissection. World J Gastroenterol.
2005;11(30):4623–7.
4. Jang HJ, Kim JH, Song HH, Woo KH, Kim M, Kae SH, et al.
Clinical outcomes of patients with liver cirrhosis who underwent
curative surgery for gastric cancer: a retrospective multi-center
study. Dig Dis Sci. 2008;53(2):399–404.
5. Guo F, Ma S, Yang S, Dong Y, Luo F, Wang Z. Surgical strategy
for gastric cancer patients with liver cirrhosis: a retrospective
cohort study. Int J Surg. 2014;12(8):810–4.
6. Japanese Gastric Cancer Association. Japanese gastric cancer
treatment guidelines 2010 (ver. 3). Gastric Cancer.
2011;14(2):113–23.
7. Kim HH, Han SU, Kim MC, Hyung WJ, Kim W, Lee HJ, et al.
Long-term results of laparoscopic gastrectomy for gastric cancer:
a large-scale case-control and case-matched Korean multicenter
study. J Clin Oncol. 2014;32(7):627–33.
8. Japanese Gastric Cancer Association. Japanese gastric cancer
treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016 [Epub
ahead of print].
Table 5 Long-term recurrence
and death
OG (48) LG (27) P value
Mean follow-up period (month) 55.5 ± 35.9 46.8 ± 27.8 0.248
Recurrence 2 1 1.000
Cause of death 0.313
Gastric cancer 2 0
Liver 4 1
Other cause 2 1
OG open gastrectomy group, LG laparoscopic or laparoscopic-assisted gastrectomy group
Comparison of long-term survival and immediate postoperative liver function after…
123
9. Cobb WS, Heniford BT, Burns JM, Carbonell AM, Matthews
BD, Kercher KW. Cirrhosis is not a contraindication to laparo-
scopic surgery. Surg Endosc. 2005;19(3):418–23.
10. Kang SJ, Jung MR, Cheong O, Park YK, Kim HG, Kim DY, et al.
Is laparoscopy-assisted radical gastrectomy safe in patients with
Child-Pugh class A cirrhosis? J Gastric Cancer. 2013;13(4):
207–13.
11. Yoon HM, Yang HK, Lee HJ, Park DJ, Kim HH, Lee KU, et al.
Comparison of liver function after laparoscopically assisted and
open distal gastrectomies for patients with liver disease. Surg
Endosc. 2011;25(6):1761–5.
12. Kim HS, Kim MG, Kim BS, Lee IS, Lee S, Yook JH, et al.
Comparison of totally laparoscopic total gastrectomy and
laparoscopic-assisted total gastrectomy methods for the surgical
treatment of early gastric cancer near the gastroesophageal
junction. J Laparoendosc Adv Surg Tech A. 2013;23(3):
204–10.
13. Etoh T, Shiraishi N, Tajima M, Shiromizu A, Yasuda K, Inomata
M, et al. Transient liver dysfunction after laparoscopic gastrec-
tomy for gastric cancer patients. World J Surg. 2007;31:1115–20.
14. Cheng H, Hsiao CW, Clymer JW, Schwiers ML, Tibensky BN,
Patel L, et al. Gastrectomy and D2 lymphadenectomy for gastric
cancer: a meta-analysis comparing the Harmonic scalpel to
conventional techniques. Int J Surg Oncol. 2015;2015:397260.
15. Ryu KW, Lee JH, Kim YW, Park JW, Bae JM. Management of
ascites after radical surgery in gastric cancer patients with liver
cirrhosis and minimal hepatic dysfunction. World J Surg.
2005;29:653–6.
16. Isozaki H, Okajima K, Ichinona T, Fujii K, Nomura E, Izumi N.
Surgery for gastric cancer in patients with cirrhosis. Surg Today.
1997;27:17–21.
17. Ikeda Y, Kanda T, Kosugi S, Yajima K, Matsuki A, Suzuki T,
et al. Gastric cancer surgery for patients with liver cirrhosis.
World J Gastrointest Surg. 2009;1:49–55.
A. A. Saeed et al.
123
